AU2002338666A1 - Multiplication of viruses in a cell culture - Google Patents
Multiplication of viruses in a cell cultureInfo
- Publication number
- AU2002338666A1 AU2002338666A1 AU2002338666A AU2002338666A AU2002338666A1 AU 2002338666 A1 AU2002338666 A1 AU 2002338666A1 AU 2002338666 A AU2002338666 A AU 2002338666A AU 2002338666 A AU2002338666 A AU 2002338666A AU 2002338666 A1 AU2002338666 A1 AU 2002338666A1
- Authority
- AU
- Australia
- Prior art keywords
- viruses
- multiplication
- cell culture
- culture
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title 1
- 238000004113 cell culture Methods 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10144903.8 | 2001-09-12 | ||
DE10144903A DE10144903A1 (en) | 2001-09-12 | 2001-09-12 | Replication of virus in cell cultures, useful for preparing vaccines and diagnostic reagents, where replication of cells and virus is simultaneous |
PCT/EP2002/010207 WO2003023025A1 (en) | 2001-09-12 | 2002-09-11 | Multiplication of viruses in a cell culture |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002338666A1 true AU2002338666A1 (en) | 2003-06-19 |
AU2002338666B2 AU2002338666B2 (en) | 2008-11-20 |
Family
ID=7698761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002338666A Ceased AU2002338666B2 (en) | 2001-09-12 | 2002-09-11 | Multiplication of viruses in a cell culture |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050118698A1 (en) |
EP (1) | EP1427817B1 (en) |
JP (2) | JP2005502357A (en) |
KR (1) | KR100968141B1 (en) |
AT (1) | ATE466932T1 (en) |
AU (1) | AU2002338666B2 (en) |
BR (1) | BR0212469A (en) |
CA (1) | CA2456561A1 (en) |
CY (1) | CY1110716T1 (en) |
DE (2) | DE10144903A1 (en) |
DK (1) | DK1427817T3 (en) |
ES (1) | ES2345606T3 (en) |
HK (1) | HK1062029A1 (en) |
NZ (1) | NZ532203A (en) |
PT (1) | PT1427817E (en) |
SI (1) | SI1427817T1 (en) |
WO (1) | WO2003023025A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101094915A (en) * | 2004-05-20 | 2007-12-26 | 益得生物医学公司 | Process for the production of an influenza vaccine |
DE602005024827D1 (en) | 2004-09-09 | 2010-12-30 | Novartis Vaccines & Diagnostic | REDUCTION OF POTENTIAL IATROGENIC RISKS ASSOCIATED WITH INFLUENZA VACCINES |
NZ567817A (en) | 2005-11-01 | 2012-01-12 | Novartis Vaccines & Diagnostic | Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment |
US20110180430A1 (en) | 2005-11-04 | 2011-07-28 | Novartis Vaccines And Diagnostics Srl | Adjuvanted influenza vaccines including cytokine-inducing agents |
CA2628152C (en) | 2005-11-04 | 2016-02-02 | Novartis Vaccines And Diagnostics S.R.L. | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
EA014028B1 (en) | 2005-11-04 | 2010-08-30 | Новартис Вэксинс Энд Диагностикс Срл | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
NZ568211A (en) | 2005-11-04 | 2011-11-25 | Novartis Vaccines & Diagnostic | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
WO2007052155A2 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
EP2004226A1 (en) | 2006-03-24 | 2008-12-24 | Novartis Vaccines and Diagnostics GmbH & Co. KG | Storage of influenza vaccines without refrigeration |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
CA2663196A1 (en) * | 2006-09-11 | 2008-03-20 | Novartis Ag | Making influenza virus vaccines without using eggs |
WO2008105931A2 (en) | 2006-09-15 | 2008-09-04 | Medimmune Vaccines, Inc. | Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
EA201070066A1 (en) | 2007-06-27 | 2010-06-30 | Новартис Аг | VACCINES AGAINST FLU WITH LOW CONTENT OF ADDITIVES |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
CN102215865B (en) | 2008-09-24 | 2013-10-30 | 米迪缪尼有限公司 | Methods for purification of viruses |
CN102216450B (en) | 2008-09-24 | 2014-05-14 | 米迪缪尼有限公司 | Methods for cultivating cells, propagating and purifying viruses |
US20110217330A1 (en) | 2008-11-05 | 2011-09-08 | Bruno Rene Andre | Novel method |
DE102010018462A1 (en) | 2009-04-27 | 2011-04-07 | Novartis Ag | Vaccines for protection against influenza |
AU2010309404B2 (en) * | 2009-10-20 | 2015-07-09 | Seqirus UK Limited | Improved reverse genetics methods for virus rescue |
JP2013523175A (en) | 2010-04-14 | 2013-06-17 | イーエムディー・ミリポア・コーポレーション | Method for producing high-titer and high-purity virus stock and method for using the same |
BR112012028146A2 (en) | 2010-05-06 | 2015-09-15 | Novartis Ag | organic peroxide compounds for inactivation of microorganisms |
EP2571520B1 (en) | 2010-05-21 | 2018-04-04 | Seqirus UK Limited | Influenza virus reassortment method |
PL2575872T3 (en) | 2010-06-01 | 2021-02-22 | Seqirus UK Limited | Concentration of influenza vaccine antigens without lyophilization |
JP5976639B2 (en) | 2010-06-01 | 2016-08-23 | ノバルティス アーゲー | Concentration and lyophilization of influenza vaccine antigens |
AU2011290471B2 (en) | 2010-08-20 | 2015-08-20 | Novartis Ag | Soluble needle arrays for delivery of influenza vaccines |
DK2675476T3 (en) * | 2011-02-17 | 2015-12-14 | Boehringer Ingelheim Vetmed | Process for producing PRRSV on a commercial scale |
CA2829774C (en) | 2011-03-14 | 2019-09-24 | National Research Council Of Canada | Method of viral production in cells |
GB201216121D0 (en) | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
CA2866465A1 (en) | 2012-03-06 | 2013-09-12 | Crucell Holland B.V. | Improved vaccination against influenza |
US20150210986A1 (en) * | 2012-08-24 | 2015-07-30 | Ge Healthcare Bio-Sciences Corp. | Virus purification and formulation process |
KR101370512B1 (en) | 2013-06-07 | 2014-03-06 | 재단법인 목암생명공학연구소 | Mdck-derived cell lines suspension-cultured in a protein-free medium and method for propagating virus using the same |
US11013795B2 (en) | 2015-06-26 | 2021-05-25 | Seqirus UK Limited | Antigenically matched influenza vaccines |
HUE051783T2 (en) | 2015-07-07 | 2021-03-29 | Seqirus Uk Ltd | Method for quantifying immunogenic hemagglutinin |
CN105561317B (en) * | 2015-12-22 | 2018-03-20 | 肇庆大华农生物药品有限公司 | Recombinant pseudorabies virus vaccine heat-resisting lyophilized protecting agent and preparation method thereof |
CN108239619A (en) * | 2016-12-23 | 2018-07-03 | 甘肃健顺生物科技有限公司 | The second order culture process technology of suspension mdck cell related vaccines production |
CN108570444A (en) * | 2017-11-09 | 2018-09-25 | 甘肃健顺生物科技有限公司 | ST cells tame suspension process and second order virus production technique |
CN108570445A (en) * | 2017-11-09 | 2018-09-25 | 甘肃健顺生物科技有限公司 | PK15 cells tame suspension process and second order virus production technique |
CN108570454A (en) * | 2017-11-09 | 2018-09-25 | 甘肃健顺生物科技有限公司 | MDBK tames suspension process and second order virus production technique |
IL293031A (en) | 2019-11-18 | 2022-07-01 | Seqirus Pty Ltd | Method for producing reassortant influenza viruses |
KR102444684B1 (en) * | 2020-04-29 | 2022-09-16 | 에스케이바이오사이언스(주) | Method for producing influenza virus using single-use cultivation process system |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19612966B4 (en) * | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK cells and methods of propagating influenza viruses |
US6110724A (en) * | 1996-10-18 | 2000-08-29 | The Research Foundation For Microbial Diseases Of Osaka University | Rotavirus antigen, vaccine and diagnostic agent for rotavirus infections, and a method for producing the antigen |
GB9915413D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Propagation method |
DE60142506D1 (en) * | 2000-03-03 | 2010-08-19 | Chemo Sero Therapeut Res Inst | CELL USED IN SERUM FREE CULTURE, CULTURAL SUSPENSION AND PROCEDURE FOR VIRUS PRODUCTION AS A VACCINATE USING THE CELL |
-
2001
- 2001-09-12 DE DE10144903A patent/DE10144903A1/en not_active Ceased
-
2002
- 2002-09-11 KR KR1020047003711A patent/KR100968141B1/en active IP Right Grant
- 2002-09-11 NZ NZ532203A patent/NZ532203A/en not_active IP Right Cessation
- 2002-09-11 DK DK02777068.4T patent/DK1427817T3/en active
- 2002-09-11 WO PCT/EP2002/010207 patent/WO2003023025A1/en active IP Right Grant
- 2002-09-11 PT PT02777068T patent/PT1427817E/en unknown
- 2002-09-11 ES ES02777068T patent/ES2345606T3/en not_active Expired - Lifetime
- 2002-09-11 US US10/487,709 patent/US20050118698A1/en not_active Abandoned
- 2002-09-11 JP JP2003527090A patent/JP2005502357A/en active Pending
- 2002-09-11 BR BR0212469-6A patent/BR0212469A/en not_active IP Right Cessation
- 2002-09-11 EP EP02777068A patent/EP1427817B1/en not_active Expired - Lifetime
- 2002-09-11 DE DE50214416T patent/DE50214416D1/en not_active Expired - Lifetime
- 2002-09-11 CA CA002456561A patent/CA2456561A1/en not_active Abandoned
- 2002-09-11 AU AU2002338666A patent/AU2002338666B2/en not_active Ceased
- 2002-09-11 AT AT02777068T patent/ATE466932T1/en active
- 2002-09-11 SI SI200230909T patent/SI1427817T1/en unknown
-
2004
- 2004-07-08 HK HK04104986.4A patent/HK1062029A1/en not_active IP Right Cessation
-
2010
- 2010-06-25 JP JP2010145663A patent/JP2010246559A/en active Pending
- 2010-07-30 CY CY20101100718T patent/CY1110716T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002338666A1 (en) | Multiplication of viruses in a cell culture | |
AU2002368042A1 (en) | Photovoltaic cell | |
AU2001252014A1 (en) | Photovoltaic cell | |
AU2001254885A1 (en) | Modified ES cells and ES cell-specific gene | |
AU2001240126A1 (en) | Lithium cell | |
AU2002317418A1 (en) | Cell enumeration | |
AU2002225997A1 (en) | Two chamber cell culture vessel | |
EP1333086A4 (en) | Cell culture case | |
AU2003260351A1 (en) | Cell culture insert | |
AU2002325758A1 (en) | Cultured stromal cells and uses thereof | |
AU3943401A (en) | Cell cycle progression proteins | |
AU2001235452A1 (en) | Cell culture media | |
AU2001252015A1 (en) | Photovoltaic cell | |
AU2002246422A1 (en) | Cell culture plate and system using the same | |
AU6001401A (en) | Flat lithium cell | |
AU2003224085A1 (en) | Waveguide in porous substrates | |
AU2001275897A1 (en) | Improvement of cell culture performance | |
AU2002225693A1 (en) | Optimized antitrypsin expression in rice cell culture | |
AUPR968801A0 (en) | Improvements in enzyme stability | |
AU2003260552A1 (en) | Cell culture device | |
AU2002329162A1 (en) | Cell culture system | |
AU2003258420A1 (en) | Model epithelial cell cultures | |
GB2394477B (en) | Cell culture | |
AU2002235429A1 (en) | Cell culture vessel | |
AU2002253670B2 (en) | Redox-flow cell electrolyte and redox-flow cell |